HEMEDEX INC. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (MIT) to quantify tissue perfusion (i.e., blood flow at the capillary level). This technology addresses the need for real-time, prognostic data in complex medical and surgical procedures. These complex procedures often involve compromised vasculature, delayed ischemia, or other serious pathophysiology, resulting in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. HEMEDEX's patented technology can provide an early warning of impending tissue ischemia, help target appropriate therapies, and rapidly assess the effect of interventions on cerebral blood flow (CBF), thus providing clinicians with a powerful tool to enhance patient care. HEMEDEX is ISO 13485:2012 certified.
View Top Employees from HEMEDEX INC.Website | http://www.hemedex.com |
Revenue | $5 million |
Employees | 11 (7 on RocketReach) |
Founded | 2000 |
Address | 564 Main St, Waltham, Massachusetts, US |
Phone | (617) 577-1759 |
Fax | (617) 577-9328 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, CRM, Manufacturing, Information Technology, Sales and Marketing, Software, Internet, Internet Services |
Competitors | Biometrix, Bionet America Animal Health, Juvent, MEDIcept Inc., Orthocare Innovations, LLC |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular HEMEDEX INC. employee's phone or email?
The HEMEDEX INC. annual revenue was $5 million in 2024.
Dean Honkonen is the Vice President, Ra and QA of HEMEDEX INC..
7 people are employed at HEMEDEX INC..
HEMEDEX INC. is based in Waltham, Massachusetts.
The NAICS codes for HEMEDEX INC. are [33, 334].
The SIC codes for HEMEDEX INC. are [384, 38].